rs121908698
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121908701
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs121908702
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs137853009
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs137853010
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs137853011
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs141568342
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs143611747
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs200917541
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs540635787
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs555607708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs560596101
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587780189
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs587781667
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs587781705
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782401
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs72552322
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs730881701
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs77130927
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs778212685
|
|
|
0.010 |
GeneticVariation |
BEFREE |
CHEK2 truncating mutations (IVS2 + 1G>A or 1100delC) were identified in 9 of 1921 controls (0.5%) and in 11 of 690 (1.6%) unselected patients with prostate cancer [odds ratio (OR) = 3.4; P = 0.004].
|
15087378 |
2004 |
rs786203472
|
|
|
0.010 |
GeneticVariation |
BEFREE |
CHEK2 truncating mutations (IVS2 + 1G>A or 1100delC) were identified in 9 of 1921 controls (0.5%) and in 11 of 690 (1.6%) unselected patients with prostate cancer [odds ratio (OR) = 3.4; P = 0.004].
|
15087378 |
2004 |
rs863224748
|
|
|
0.010 |
GeneticVariation |
BEFREE |
CHEK2 truncating mutations (IVS2 + 1G>A or 1100delC) were identified in 9 of 1921 controls (0.5%) and in 11 of 690 (1.6%) unselected patients with prostate cancer [odds ratio (OR) = 3.4; P = 0.004].
|
15087378 |
2004 |
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Early detection of prostate cancer: AUA Guideline.
|
23659877 |
2013 |